Connecticut Life Science

Quantum-Si Debuts New HQ in Connecticut

Branford, CT – Quantum-Si- Incorporated, The Protein Sequencing Company, announced the official debut of the company’s new state-of-the-art, 29,420sf headquarters in Branford.

The new facility extends the company’s decade-long history in Connecticut, and includes a seven-year lease which will keep Quantum-Si in Branford at least through 2029. The official ribbon cutting, hosted on June 6, featured remarks from Quantum-Si CEO, Jeff Hawkins; Quantum-Si founder and chairman, Jonathan Rothberg, PhD.; and special guests Connecticut Governor Ned Lamont, U.S. Senator Richard Blumenthal (D-CT), and Alexandra Daum, the commissioner of the Connecticut Department of Economic and Community Development (DECD).

At the ribbon cutting: Senator Richard Blumenthal; Jeff Hawkins; Governor Ned Lamont; and Jonathan Rothberg

The new facility, located at 29 Business Park Drive, provides the resources necessary for increased operational scale, development, and collaboration. This milestone represents Quantum-Si’s anticipated growth trajectory and ability to support customers and partners using Platinum, a next-generation single-molecule protein sequencing platform.

“The cities of Branford and Guilford, and State of Connecticut have been incredible partners to Quantum-Si since our founding. Our company’s roots are here, our relationships are here, and we want to continue building a world-class company here,” said Hawkins. “Our new headquarters reflects the company’s ongoing commitment to job opportunities and innovation alongside the local community. We believe New Haven County is the perfect strategic location to attract world-class scientific talent as we seek to grow our teams. We look forward to leading the expansion of the life sciences industry in Connecticut.”

“We have a truly transformative product on the market in Platinum, the next-generation protein sequencer, a leadership bench of highly experienced executives, and now we have the facilities to scale alongside that growth,” said Rothberg. “Next-generation protein sequencing will be critical for the discovery of a new wave of precision therapies, and I am proud to see this work being done in the community I call home.”

“Quantum-Si’s clear commitment to cutting edge technology – and to Connecticut – are truly thrilling. Connecticut has a long history and tradition of being at the forefront of innovation and Quantum-Si carries on that legacy with their next generation protein sequencers that are advancing and accelerating our understanding of medicine and human health,” said Blumenthal. “I am grateful and excited to have celebrated this milestone today and look forward to Quantum-Si’s future endeavors in our state.”